Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Idea Of The Day -- Ignore unavailable to you. Want to Upgrade?

To: J.T. who wrote (22954)	1/26/1999 9:37:00 PM
From: silInv	Respond to of 50167

J.T. Thanks. I saw MTC a few days ago and saw the news here before the close. Just wonder whether if there is chance tomorrow to get it without paying too much. Do you know how much this will benefit MTC and how much for PFE? Also curious about the real data behind the sales without the giving away part? ================================================================== Free Samples The company crafted a plan under which doctors will soon be giving free samples of Celebrex to patients. That may affect weekly prescription numbers in the near term, said Richard Stover, an analyst with Arnhold & S. Bleichroeder who has an ''attractive'' on Monsanto. Stover cautioned against drawing too much from the early numbers. ''At the end of February, early March is where you're going to see the real numbers hit,'' he said. Still, ''There's no question that this is going to be a very sizable drug.'' silInv